141
Views
17
CrossRef citations to date
0
Altmetric
Original Research

Effect of a structured, active, home-based cancer-treatment program for the management of patients on oral chemotherapy

, , , , , , , & show all
Pages 917-923 | Published online: 25 Jun 2014

References

  • JemalAWardEThunMDeclining death rates reflect progress against cancerPloS One201053e958420231893
  • JemalABrayFCenterMMFerlayJWardEFormanDGlobal cancer statisticsCA Cancer J Clin2011612699021296855
  • HwangSYChangSJParkBWDoes chemotherapy really affect the quality of life of women with breast cancer?J Breast Cancer201316222923523843858
  • ReeveBBPotoskyALSmithAWImpact of cancer on health-related quality of life of older AmericansJournal of the National Cancer Institute20091011286086819509357
  • GrantMSunVFujinamiRFamily caregiver burden, skills preparedness, and quality of life in non-small cell lung cancerOncol Nurs Forum201340433734623803267
  • BirnerAPharmacology of oral chemotherapy agentsClin J Oncol Nurs200376 Suppl111914705495
  • O’NeillVJTwelvesCJOral cancer treatment: developments in chemotherapy and beyondBr J Cancer200287993393712434279
  • De PortuSMantovaniLGRavaioliACost analysis of capecitabine vs 5-fluorouracil-based treatment for metastatic colorectal cancer patientsJ Chemother201022212512820435573
  • SanonMTaylorDCParthanACoombsJPaolantonioMSasaneMCost-effectiveness of 3-years of adjuvant imatinib in gastrointestinal stromal tumors (GIST) in the United StatesJ Med Econ201316115015922762291
  • CammàCCabibboGPettaSWEF study groupSOFIA study groupCost-effectiveness of sorafenib treatment in field practice for patients with hepatocellular carcinomaHepatology20135731046105423299720
  • DemetriGDvon MehrenMBlankeCDEfficacy and safety of imatinib mesylate in advanced gastrointestinal stromal tumorsN Engl J Med2002347747248012181401
  • RammohanASathyanesanJRajendranKA gist of gastrointestinal stromal tumors: A reviewWorld J Gastrointest Oncol20135610211223847717
  • WeingartSNBrownEBachPBNCCN Task Force Report: Oral chemotherapyJ Natl Compr Canc Netw20086Suppl 3S1S1418377852
  • HoffPMAnsariRBatistGComparison of oral capecitabine versus intravenous fluorouracil plus leucovorin as first-line treatment in 605 patients with metastatic colorectal cancer: results of a randomized phase III studyJ Clin Oncol20011982282229211304782
  • O’ShaughnessyJMilesDVukeljaSSuperior survival with capecitabine plus docetaxel combination therapy in anthracycline-pretreated patients with advanced breast cancer: phase III trial resultsJ Clin Oncol200220122812282312065558
  • Van CutsemETwelvesCCassidyJXeloda Colorectal Cancer Study GroupOral capecitabine compared with intravenous fluorouracil plus leucovorin in patients with metastatic colorectal cancer: results of a large phase III studyJ Clin Oncol200119214097410611689577
  • OkinesAFNormanARMcCloudPKangYKCunninghamDMeta-analysis of the REAL-2 and ML17032 trials: evaluating capecitabine-based combination chemotherapy and infused 5-fluorouracil-based combination chemotherapy for the treatment of advanced oesophago-gastric cancerAnn Oncol20092091529153419474114
  • Effects of vinorelbine on quality of life and survival of elderly patients with advanced non-small-cell lung cancer. The Elderly Lung Cancer Vinorelbine Italian Study GroupJ Natl Cancer Inst199991166729890172
  • Le ChevalierTBrisgandDDouillardJYRandomized study of vinorelbine and cisplatin versus vindesine and cisplatin versus vinorelbine alone in advanced non-small-cell lung cancer: results of a European multicenter trial including 612 patientsJ Clin Oncol19941223603678113844
  • FreytesCOIndications and complications of intravenous devices for chemotherapyCurr Opin Oncol200012430330710888414
  • PartridgeAHAvornJWangPSWinerEPAdherence to therapy with oral antineoplastic agentsJ Natl Cancer Inst200294965266111983753
  • RuddyKMayerEPartridgeAPatient adherence and persistence with oral anticancer treatmentCA Cancer J Clin2009591566619147869
  • van LeeuwenRWBrundelDHNeefCPrevalence of potential drug–drug interactions in cancer patients treated with oral anticancer drugsBr J Cancer201310851071107823412102
  • GebbiaVBellaviaGFerraùFValerioMRAdherence, compliance and persistence to oral antineoplastic therapy: a review focused on chemotherapeutic and biologic agentsExpert Opin Drug Saf201211Suppl 1S49S5922149481
  • LebovitsAHStrainJJSchleiferSJTanakaJSBhardwajSMesseMRPatient noncompliance with self-administered chemotherapyCancer199065117222293862
  • OsterbergLBlaschkeTAdherence to medicationN Engl J Med2005353548749716079372
  • TappendenPCampbellFRawdinAWongRKalitaNThe clinical effectiveness and cost-effectiveness of home-based, nurse-led health promotion for older people: a systematic reviewHealth Technol Assess2012162017222490205
  • RaphaëlRYvesDGiselleCMagaliMOdileCMCancer treatment at home or in the hospital: what are the costs for French public health insurance? Findings of a comprehensive-cancer centreHealth Policy200572214114815802149
  • AaronsonNKAhmedzaiSBergmanBThe European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncologyJ Natl Cancer Inst19938553653768433390
  • CellaDDavisKBreitbartWCurtGFatigue CoalitionCancer-related fatigue: prevalence of proposed diagnostic criteria in a United States sample of cancer survivorsJ Clin Oncol200119143385339111454886
  • RüfferJUFlechtnerHTrallsPGerman Hodgkin Lymphoma Study GroupFatigue in long-term survivors of Hodgkin’s lymphoma; a report from the German Hodgkin Lymphoma Study Group (GHSG)Eur J Cancer200339152179218614522376
  • van den Beuken-van EverdingenMH1de RijkeJMKesselsAGSchoutenHCvan KleefMPatijnJPrevalence of pain in patients with cancer: a systematic review of the past 40 yearsAnn Oncol20071891437144917355955
  • LavianoAMeguidMMRossi-FanelliFCancer anorexia: clinical implications, pathogenesis, and therapeutic strategiesLancet Oncol200341168669414602249
  • MacciòAMadedduCMantovaniGCurrent pharmacotherapy options for cancer anorexia and cachexiaExpert Opin Pharmacother201213172453247223072481
  • PetersLSellickKQuality of life of cancer patients receiving inpatient and home-based palliative careJ Adv Nurs200653552453316499673
  • BornerMMDietrichDStuppRPhase II study of capecitabine and oxaliplatin in first- and second-line treatment of advanced or metastatic colorectal cancerJ Clin Oncol20022071759176611919232
  • LiuGFranssenEFitchMIWarnerEPatient preferences for oral versus intravenous palliative chemotherapyJ Clin Oncol19971511101158996131
  • LoveRRCameronLConnellBLLeventhalHSymptoms associated with tamoxifen treatment in postmenopausal womenArch Intern Med19911519184218471888251
  • MolassiotisABrearleySSaundersMEffectiveness of a home care nursing program in the symptom management of patients with colorectal and breast cancer receiving oral chemotherapy: a randomized, controlled trialJ Clin Oncol200927366191619819917849
  • BordonaroSRaitiFDi MariAActive home-based cancer treatmentJ Multidiscip Healthc2012513714322807631
  • TemelJSGreerJAMuzikanskyAEarly palliative care for patients with metastatic non-small-cell lung cancerN Engl J Med2010363873374220818875
  • BhattacharyaDEasthallCWilloughbyKASmallMWatsonSCapecitabine non-adherence: exploration of magnitude, nature and contributing factorsJ Oncol Pharm Pract201218333334222298660